Dorton Katina
SEC-identified person · CIK 1617541 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Prelude Therapeutics Inc PRLD | Director | filed 2025 - 2026 |
| Mallinckrodt plc MNKTQ | Director | filed 2024 - 2026 |
| Tscan Therapeutics, Inc. TCRX | Director | filed 2021 - 2026 |
| Fulcrum Therapeutics, Inc. FULC | Director | filed 2020 - 2025 |
| US Ecology, Inc. ECOL | Director | filed 2019 - 2022 |
| Pandion Therapeutics, Inc. PAND | Director | filed 2020 - 2021 |
| US Ecology Holdings, Inc. ECOL | Director | filed 2014 - 2019 |
| Tectonic Therapeutic, Inc. TECX | Chief Financial Officer | filed 2018 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.